The African-American Heart Failure Trial: background, rationale and significance.

New treatments have improved outcomes in heart failure (HF), but applicability of these advances may be limited in African Americans. Analysis of previous trials has shown that a combination of hydralazine (H) plus isosorbide dinitrate (ISDN) may be especially beneficial in African Americans with HF...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Taylor, Anne L., Cohn, Jay N., Worcel, Manuel, Franciosa, Joseph A.
Format: Artigo
Idioma:Inglês
Publicat: National Medical Association 2002
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2594160/
https://ncbi.nlm.nih.gov/pubmed/12392039
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars